NSETrading Window28 Sept 2026 · 28 Sept 2026, 02:51 pm

Trading Window

Indoco Remedies Limited · INDOCO

✦ AI Summary

Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed from 01st October, 2026 until 48 hours after the declaration of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

INDOCO_28092026145106_Closure_of_TW_QE_30092026.pdf

pdf

Download →
View document text
Date:- 28th September, 2026 To To The Listing Department The Listing Department National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Floor 25, P. J. Bandra – Kurla Complex Towers, Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Stock Code : 532612 Stock Code : INDOCO Dear Sir/Madam, Sub: Intimation regarding Closure of Trading Window Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s code of conduct for regulating, monitoring and reporting of trading by insiders, this is to inform you that the Trading Window for trading/dealing in Equity Shares of the Company will remain closed from Thursday, 01st October, 2026 until 48 hours after declaration of Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year Ended 30th September, 2026. During the closure of trading window, all designated persons of the Company (including their immediate relatives) have been advised not to deal in Equity Shares of the Company. The date of the Board Meeting of the Company for declaration of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026, will be intimated in due course. You are requested to kindly take the same on record Thanking you, Yours faithfully, For Indoco Remedies Limited Ramanathan Hariharan Company Secretary & Head Legal